London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
In line with Walbrook previously,I’m not sure Mologic CE marking or increases in production will give any traction to sp. On their logic Mologic , is not odx and ramp up figures already given in presentation, not Rns.
If £75 mill contract already provided to Abingdon and this is treated as not an order which will probably be filled in batches then not sure new news will follow This single £75m non order represents probably our whole capacity for next six months, so not necessarily new news. Mhra may never come therefore any decent news for substantial rise may not come for six months being conservative. My worry here has always been that we have the golden goose and typically of aim, someone will engineer price suppression , hide newsworthy data and steal odx from right under our noses. Watch the price rocket then. I seriously want to be wrong but very cynical of aim. I don’t think in that instance anyone will lose out financially but we will all miss the miltibagger of a lifetime. We’ll see in the coming months.
That's also my concern symbol.
The ceo alluded to an investor coming on board. If they do then where will the shares come from in order to hold a stake. If think if it does happen it will end in some sort of takeover inmv
Symbo , what are you on about .
The gvt are going to order £75 m worth of tests from consortium . Yes that may be over 6 months , but post Mhra approval then it will be rns . So in November we will get that order I am sure . Where do you get 6 months to get an order from
Symbo are you kidding!! You think Mologic CE marking the antigen lateral flow test that the whole world is waiting for and we will be producing as much as possible wont add value???
It has been a tough ride with sellers that have been in since 7p taking significant profits. Firstly those sellers are running dry, and secondly the size of some of the news coming will flip out any remaining sellers. We have a couple of pieces of news that can lead to trading volume of 50% plus of the company in a single day. The news delivered so far has not achieved the value it deserves, but the balance will be restored. Seen it many times. 2.5m tests = £260m profit. It cannot keep getting ignored and every month we are moving quickly towards that target now.
Merch
Correct mate, honestly its inconceivable that Mologic CE mark the Antigen test and start a tech transfer to ODX and it has no impact on the SP. Its only the most in demand test in the WHOLE world.
I will add one thing here,
TT normally takes 6-8 weeks, but CK has advised they are aiming for 4 weeks. That's not because of us impatient share holders.
First to the finish line or as close to the ones who have finished is paramount in order to steal a market share. For all we know we could end up supplying Scotland. They know its the moonshot.
Safy - first to market isn't necessarily the most important. Demand will greatly exceed supply. Sona showed yesterday that performance is the main factor. It has to be highly sensitive and specific. Mologic have already proven they can deliver tests of the required performance quality.
It has to be high performing and low cost and we will achieve that.
I believe MHRA approval of antibody self tests is just because they don't want us to have them yet. It sounds like they are no longer looking for immunity passports, so may still do a mass screen or if the vaccine arrives in the next few months they may work with the vaccine roll out.
Mhra approval can take 210 days.did the company indicate that it is being fast tracked So at worst we should have this by the end of December.
Just listening again. CK said something along the lines of ......
They believe the capacity they are building will be consumed based on conversations with stakeholders to understand demand, they are not just building it for the sake of it.